55 related articles for article (PubMed ID: 38760717)
1. ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1.
Song W; Tang L; Xu Y; Sun Q; Yang F; Guan X
J Exp Clin Cancer Res; 2017 Jun; 36(1):75. PubMed ID: 28583190
[TBL] [Abstract][Full Text] [Related]
2. PLAU promotes cell proliferation and migration of head and neck cancer via STAT3 signaling pathway.
Cui X; Sun H; Liu X; Bai Y; Bai Y; Cui Y; Wang B; Zhang S; Li X
Exp Cell Res; 2024 May; 438(2):114056. PubMed ID: 38663475
[TBL] [Abstract][Full Text] [Related]
3. PTGER3 knockdown inhibits the vulnerability of triple-negative breast cancer to ferroptosis.
Wang S; Zhang Y; Zhang D; Meng J; Che N; Zhao X; Liu T
Cancer Sci; 2024 Jun; 115(6):2067-2081. PubMed ID: 38566528
[TBL] [Abstract][Full Text] [Related]
4. The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.
Yan Z; Zhong Z; Shi C; Feng M; Feng X; Liu T
Cancer Biol Ther; 2024 Dec; 25(1):2355705. PubMed ID: 38778753
[TBL] [Abstract][Full Text] [Related]
5. Constructing a novel prognostic model for triple-negative breast cancer based on genes associated with vasculogenic mimicry.
Ren Y; Feng L; Tan Z; Zhou F; Liu S
Aging (Albany NY); 2024 May; 16(9):8086-8109. PubMed ID: 38728245
[TBL] [Abstract][Full Text] [Related]
6. Low-dose radiation decreases tumor progression via the inhibition of the JAK1/STAT3 signaling axis in breast cancer cell lines.
Kaushik N; Kim MJ; Kim RK; Kumar Kaushik N; Seong KM; Nam SY; Lee SJ
Sci Rep; 2017 Feb; 7():43361. PubMed ID: 28240233
[TBL] [Abstract][Full Text] [Related]
7. Study on the mechanism of heterogeneous tumor-associated macrophages in three subtypes of breast cancer through the integration of single-cell RNA sequencing and in vitro experiments.
Yuan Y; Zhang S; Huang J
Mol Biol Rep; 2024 Jun; 51(1):720. PubMed ID: 38824268
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling.
Peng J; Liu X; Mao Y; Lv M; Ma T; Liu J; Zhou Q; Han Y; Li X; Wang H
Mol Carcinog; 2024 May; ():. PubMed ID: 38780151
[TBL] [Abstract][Full Text] [Related]
9. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy.
Yang N; Yun WJ; Cui ZG; Zheng HC
J Obstet Gynaecol; 2024 Dec; 44(1):2347430. PubMed ID: 38835234
[TBL] [Abstract][Full Text] [Related]
10. DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.
Yang Y; Gao M; Lin Z; Chen L; Jin Y; Zhu G; Wang Y; Jin T
Oncotarget; 2017 Nov; 8(58):98708-98722. PubMed ID: 29228721
[TBL] [Abstract][Full Text] [Related]
11. SLC7A2-Mediated Lysine Catabolism Inhibits Immunosuppression in Triple Negative Breast Cancer.
Sun Y; Li Y; Jiang C; Liu C; Song Y
Crit Rev Eukaryot Gene Expr; 2024; 34(5):31-43. PubMed ID: 38842202
[TBL] [Abstract][Full Text] [Related]
12. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis.
Xie H; Ruan G; Wei L; Zhang H; Shi J; Lin S; Liu C; Liu X; Zheng X; Chen Y; Deng L; Shi H
Int Immunopharmacol; 2024 May; 136():112332. PubMed ID: 38805776
[TBL] [Abstract][Full Text] [Related]
13. Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level.
Klank RL; Decker Grunke SA; Bangasser BL; Forster CL; Price MA; Odde TJ; SantaCruz KS; Rosenfeld SS; Canoll P; Turley EA; McCarthy JB; Ohlfest JR; Odde DJ
Cell Rep; 2017 Jan; 18(1):23-31. PubMed ID: 28052252
[TBL] [Abstract][Full Text] [Related]
14.
Shen JJ; Yang X; Yu M; Li QC; Wang RY; Yu WY; Zhang JL; Chen YL; Zhu WT; Li J; Zhan ZJ; Wu R
J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38849141
[TBL] [Abstract][Full Text] [Related]
15. Bulk and single-cell RNA sequencing reveal the contribution of laminin γ2 -CD44 to the immune resistance in lymphocyte-infiltrated squamous lung cancer subtype.
Song T; Yang Y; Wang Y; Ni Y; Yang Y; Zhang L
Heliyon; 2024 May; 10(10):e31299. PubMed ID: 38803944
[TBL] [Abstract][Full Text] [Related]
16. Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway.
Wang D; Keyoumu K; Yu R; Wen D; Jiang H; Liu X; Di X; Zhang S
Mol Med; 2024 May; 30(1):61. PubMed ID: 38760717
[TBL] [Abstract][Full Text] [Related]
17. High expression of STAT3 within the tumour-associated stroma predicts poor outcome in breast cancer patients.
Morrow E; Pennel K; Hatthakarnkul P; Leslie H; Mallon E; Andersen D; Jamieson N; McMillan D; Roseweir A; Edwards J
Cancer Med; 2023 Jun; 12(12):13225-13240. PubMed ID: 37199043
[TBL] [Abstract][Full Text] [Related]
18. JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States.
Stevens LE; Peluffo G; Qiu X; Temko D; Fassl A; Li Z; Trinh A; Seehawer M; Jovanović B; Alečković M; Wilde CM; Geck RC; Shu S; Kingston NL; Harper NW; Almendro V; Pyke AL; Egri SB; Papanastasiou M; Clement K; Zhou N; Walker S; Salas J; Park SY; Frank DA; Meissner A; Jaffe JD; Sicinski P; Toker A; Michor F; Long HW; Overmoyer BA; Polyak K
Cancer Res; 2023 Jan; 83(2):264-284. PubMed ID: 36409824
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
